Lipid Nanoparticles

Feasibility Studies and cGMP Design Supporting Continuous Lipid Nanoparticle Manufacturing

Jim Ziogas

DIANT Pharma

mRNA Innovations

Technology Advances Needed to Drive Future mRNA Growth

Hagen Richter, Ph.D.

mRNA–LNP Manufacturing

The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

Lipid Nanoparticles

Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform

Antonio Costa, Ph.D.

DIANT Pharma

New Integrated mRNA Offering

Building on Experience and Investing in an Integrated mRNA Offering

Jessica Madigan; Normand Blais

BIOVECTRA

Lipid Nanoparticles

Facilitating Lipid Nanoparticle Production with a Unique Continuous Manufacturing Solution

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

Lipid Nanoparticles

Lipid Nanoparticles: Transforming the Nanomedicines Market

Antonio Costa, Ph.D.

DIANT Pharma

Lipid Nanoparticle Development

Lipid Technology for Delivery of Gene-Editing Therapies

Stephen Burgess, Ph.D.

Croda Pharma

Quality by Design

A Concerted QbD Approach to Development and Manufacturing of Nucleic Acid Therapies

Lynda Menard, Ph.D.; Grant Henderson, Ph.D.

Vernal Biosciences

Custom Lipid Nanoparticle Development

The Value of a Custom Lipid Solutions Provider for mRNA Delivery

Lauren Longobardi, Ph.D.; Rima Jaber, Ph.D.; Sebastian Detlefsen, Dr.-Ing.

Evonik

Quality in mRNA Manufacturing

Quality in Equals Quality Out in mRNA Manufacturing

Judith McCorry

Vernal Biosciences

mRNA Manufacture

Platform Processes and End-to-End Capabilities Position Vernal Biosciences as a Critical CDMO Resource for mRNA Developers

Tonia Becker

Nice Insight

Lipid Excipients

Regulatory Considerations for Lipid Excipients

Claudia Widmann; Estelle Beguin Ph.D.

MilliporeSigma

Lipid Nanoparticles

Leveraging True Expertise and Flexibility for Lipid Nanoparticle Clinical Manufacturing

Cole Byvelds, P.Eng.; Kristina Parrant

Evonik

mRNA

Integrated Support Facilitates mRNA Product Development and Commercialization

Michael Wourms; Dave Stevens

Arranta Bio

Lipid Nanoparticles

Advancing Novel Therapeutics with End-to-End Lipid Nanoparticle Development and Manufacturing

Natalia Zisman

Evonik

mRNA Therapies

Realizing the Promise of RNA Therapies with Lipid Nanoparticle Delivery

Shiksha Mantri, Ph.D.

MilliporeSigma